1. Home
  2. CVAC vs OSBC Comparison

CVAC vs OSBC Comparison

Compare CVAC & OSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • OSBC
  • Stock Information
  • Founded
  • CVAC 2000
  • OSBC 1981
  • Country
  • CVAC Germany
  • OSBC United States
  • Employees
  • CVAC N/A
  • OSBC N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • OSBC Major Banks
  • Sector
  • CVAC Health Care
  • OSBC Finance
  • Exchange
  • CVAC Nasdaq
  • OSBC Nasdaq
  • Market Cap
  • CVAC 764.4M
  • OSBC 770.5M
  • IPO Year
  • CVAC 2020
  • OSBC N/A
  • Fundamental
  • Price
  • CVAC $5.45
  • OSBC $18.87
  • Analyst Decision
  • CVAC Hold
  • OSBC Buy
  • Analyst Count
  • CVAC 3
  • OSBC 5
  • Target Price
  • CVAC $6.83
  • OSBC $20.30
  • AVG Volume (30 Days)
  • CVAC 2.2M
  • OSBC 229.5K
  • Earning Date
  • CVAC 08-14-2025
  • OSBC 07-16-2025
  • Dividend Yield
  • CVAC N/A
  • OSBC 1.26%
  • EPS Growth
  • CVAC N/A
  • OSBC N/A
  • EPS
  • CVAC 0.87
  • OSBC 1.83
  • Revenue
  • CVAC $566,039,775.00
  • OSBC $275,720,000.00
  • Revenue This Year
  • CVAC N/A
  • OSBC $21.45
  • Revenue Next Year
  • CVAC $24.04
  • OSBC $12.41
  • P/E Ratio
  • CVAC $6.26
  • OSBC $10.43
  • Revenue Growth
  • CVAC 787.60
  • OSBC 2.88
  • 52 Week Low
  • CVAC $2.37
  • OSBC $14.14
  • 52 Week High
  • CVAC $5.72
  • OSBC $19.46
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 65.07
  • OSBC 76.23
  • Support Level
  • CVAC $5.36
  • OSBC $18.78
  • Resistance Level
  • CVAC $5.45
  • OSBC $19.25
  • Average True Range (ATR)
  • CVAC 0.08
  • OSBC 0.45
  • MACD
  • CVAC -0.05
  • OSBC 0.17
  • Stochastic Oscillator
  • CVAC 58.00
  • OSBC 92.54

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About OSBC Old Second Bancorp Inc.

Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The Company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.

Share on Social Networks: